Atlas Trials

Impact of COVID-19 Vaccines on Cerebrovascular Health

Clinical trial NCT04992195 · COMPLETED

Trial details

NCT number
NCT04992195
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Study type
OBSERVATIONAL
StrokeStroke, AcuteStroke, IschemicDementiaBrain IschemiaAlzheimer DiseaseBrain DiseasesMajor Adverse Cardiovascular EventArterial ThromboembolismVenous Thromboembolism
Start date
2021-07-05
Primary completion
2026-03-31
Enrollment
415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.